SHPH
NASDAQ · Biotechnology
Shuttle Pharmaceuticals Hold
$0.64
-0.07 (-9.86%)
Open$0.67
Previous Close$0.71
Day High$0.68
Day Low$0.62
52W High$6.75
52W Low$0.50
Volume—
Avg Volume3.56M
Market Cap3.58M
P/E Ratio—
EPS$-12.88
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.31M | 2.94M | 3.37M |
| Net Income | 119.2K | 97.1K | 110.6K |
| Profit Margin | 3.6% | 3.3% | 3.3% |
| EBITDA | 181.4K | 163.4K | 177.0K |
| Free Cash Flow | 96.2K | 133.1K | 131.3K |
| Rev Growth | +15.9% | +11.7% | +12.8% |
| Debt/Equity | 0.66 | 0.73 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |